Expert Opinion On Drug Safety

Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data

An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs

Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system

Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®

Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation

Proton pump inhibitors, adverse events and increased risk of mortality

Safety of sugammadex for reversal of neuromuscular block

Current state of biologic pharmacovigilance in the European Union: improvements are needed

Are risk minimization measures for approved drugs in Europe effective? A systematic review

Can therapeutic strategies prevent and manage dyskinesia in Parkinson’s disease? An update

Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms

Analgesic treatments in people with dementia - how safe are they? A systematic review

Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis

The safety of belimumab for the treatment of systemic lupus erythematosus

The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

Benefit–risk review of different drug classes used in chronic heart failure

Immunogenicity of infliximab and adalimumab

Ivabradine for treatment of heart failure

Safety considerations in the psychopharmacology of pediatric bipolar disorder

Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia

A drug safety review of treating eosinophilic asthma with monoclonal antibodies

Fixed-dose combinations banned in India: is it the right decision? An eye-opening review

An update on the safety of prescribing opioids in pediatrics

Calciphylaxis-as a drug induced adverse event

Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesity

Safety of testosterone therapy in men with prostate cancer

Safety evaluation of adalimumab in immune-mediated inflammatory disorders: a rheumatological point of view

Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia

A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety data

The safety of treating newly diagnosed epilepsy

Development of a list of high-risk perioperative medications for the elderly: a Delphi method

A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention

Comparison of common side effects from mood stabilizers and antipsychotics between pediatric and adult patients with bipolar disorder: a systematic review of randomized, double-blind, placebo-controlled trials

The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillance

Adalimumab and etanercept adherence, persistence and switch in the treatment of psoriatic arthritis: 10-year real-life analysis

The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy

The safety of ixekizumab in psoriasis drug therapy

Evaluating the efficacy and safety of antidepressants in patients with bipolar disorder

Unresolved gustatory, olfactory and auditory adverse drug reactions to antibiotic drugs: a survey of spontaneous reporting to Eudravigilance

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update

Pediatric drug safety signal detection of non-chemotherapy drug-induced neutropenia and agranulocytosis using electronic healthcare records

Safety of bazedoxifene in Korean women with post-menopausal osteoporosis: a post-marketing surveillance study (PMSS)

Comparison of post-marketing surveillance approaches regarding infections related to tumor necrosis factor inhibitors (TNFi’s) used in treatment of autoimmune diseases

Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data

Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice

Safety of systemic therapy for noninfectious uveitis

Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing survey